These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6171393

  • 41. Synthesis, tissue distribution and tumor uptake of 99mTc- and 67Ga-tetrasulfophthalocyanine.
    Rousseau J, Ali H, Lamoureux G, Lebel E, van Lier JE.
    Int J Appl Radiat Isot; 1985 Sep; 36(9):709-16. PubMed ID: 4066065
    [Abstract] [Full Text] [Related]

  • 42. Multiple scintigraphic findings in a patient with a primary myocardial sarcoma.
    Bidula LP, Maurer AH, Denenberg BS, Charkes ND, Spann JF, Malmud LS.
    Clin Nucl Med; 1983 Oct; 8(10):474-7. PubMed ID: 6317256
    [Abstract] [Full Text] [Related]

  • 43. Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.
    Vos CM, Westera G.
    Eur J Nucl Med; 1982 Oct; 7(2):92-4. PubMed ID: 6177534
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.
    van de Poll MA, Versluis A, Rasker JJ, Jurjens H, Woldring MG.
    Nuklearmedizin; 1976 Apr; 15(2):86-90. PubMed ID: 58409
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Study of the distribution of tumor affinity metal compounds and alkaline metal compounds in the tumor tissues by macroautoradiography.
    Ando A, Ando I, Sanada S, Katayama M, Hiraki T, Doishita K, Midzukami M, Hisada K.
    Int J Nucl Med Biol; 1984 Apr; 11(2):195-201. PubMed ID: 6480263
    [No Abstract] [Full Text] [Related]

  • 50. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
    Hou DY, Hoch H, Johnston GS, Tsou KC, Farkas RJ, Miller EE.
    Eur J Nucl Med; 1983 Apr; 8(12):535-40. PubMed ID: 6199207
    [Abstract] [Full Text] [Related]

  • 51. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
    Rembelska MJ, Liniecki J.
    Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
    [Abstract] [Full Text] [Related]

  • 52. A clinical comparison of the tumour-imaging radiopharmaceuticals 67Gallium-citrate and 111Indium-labelled bleomycin.
    Paterson AH, Taylor DM, McCready VR.
    Br J Radiol; 1975 Oct; 48(574):832-42. PubMed ID: 53081
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Pharmacokinetics of 57Co-bleomycetin A5 in mice with LYO-1 lymphosarcoma during treatment with rubomycin].
    Petriev VM, Vatin OE, Prusova RM.
    Radiobiol Radiother (Berl); 1986 Oct; 27(3):353-7. PubMed ID: 2429344
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Disposition of the pulmonary toxin, bleomycin.
    Tom WM, Montgomery MR.
    Drug Metab Dispos; 1979 Oct; 7(2):90-3. PubMed ID: 89025
    [Abstract] [Full Text] [Related]

  • 59. [Histoautoradiography and radiometry in the evaluation of the tumor-seeking behavior of radionuclides].
    Kindzel'skiĭ LP, Mechev DS, Atamaniuk NP, Arungazyeva VV.
    Med Radiol (Mosk); 1982 May; 27(5):15-20. PubMed ID: 6178927
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.